Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,750 | -2,240 | -10,796 | -8,247 | -5,695 |
| Depreciation Amortization | 0 | 0 | 1 | 0 | 0 |
| Income taxes - deferred | -2 | N/A | N/A | N/A | N/A |
| Other Working Capital | -705 | 242 | -1,173 | -1,584 | -1,102 |
| Other Operating Activity | 263 | -301 | 782 | 395 | 766 |
| Operating Cash Flow | $-4,193 | $-2,299 | $-11,186 | $-9,435 | $-6,031 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 800 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $800 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 610 | 610 | 9,126 | 9,126 | 9,126 |
| Financing Cash Flow | $610 | $610 | $9,126 | $9,126 | $9,126 |
| Beginning Cash Position | 4,002 | 4,002 | 6,062 | 6,062 | 6,062 |
| End Cash Position | 1,218 | 2,313 | 4,002 | 5,753 | 9,157 |
| Net Cash Flow | $-2,784 | $-1,689 | $-2,060 | $-310 | $3,095 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,193 | -2,299 | -11,186 | -9,435 | -6,031 |
| Free Cash Flow | -4,193 | -2,299 | -11,186 | -9,435 | -6,031 |